Skip to main content
Clinical Trials/NCT01456026
NCT01456026
Completed
Not Applicable

Acute Effects of Food Advanced Glycation Endproducts on Macrovascular Function in Subjects With Type 2 Diabetes Mellitus

Profil Institut für Stoffwechselforschung GmbH1 site in 1 country19 target enrollmentJune 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 Diabetes Mellitus
Sponsor
Profil Institut für Stoffwechselforschung GmbH
Enrollment
19
Locations
1
Primary Endpoint
Postprandial Change from Baseline in Flow Mediated Dilatation
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

Recent evidence supports detrimental effects of advanced glycation endproducts (AGE) on vascular function (VF). Though, the effect of AGE-modified proteins alone on vascular function remained unknown. Therefore, the aim of our study is to investigate the effects of heat-treated, glycated beta-lactoglobulins (BLG) on vascular function in subjects with type 2 diabetes mellitus (T2DM) and to compare it to non-glycated, heat-treated BLG.

Detailed Description

In a double-blind, controlled, randomized, cross-over manner, 19 subjects with T2DM will receive on 2 different days beverages containing either glycated, heat-treated BLG or non-glycated, heat-treated BLG. Macrovascular (brachial ultrasound of flow mediated dilatation -FMD) and microvascular function (laser-doppler measurements of reactive hyperemia at the hand) at baseline (T0), as well as 90 (T90) and 180 (T180) minutes after each beverage will be measured.

Registry
clinicaltrials.gov
Start Date
June 2009
End Date
May 2010
Last Updated
14 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Type 2 diabetes mellitus

Exclusion Criteria

  • Other types of diabetes
  • Major cardiovascular complications within 6 months prior to screening
  • Major diabetes complications
  • Failure to give informed consent

Outcomes

Primary Outcomes

Postprandial Change from Baseline in Flow Mediated Dilatation

Time Frame: Baseline, 90 and 180 min after oral intake of food AGE

Macrovascular (brachial ultrasound of flow mediated dilatation -FMD) will be measured at baseline (T0), as well as 90 (T90) and 180 (T180) minutes after each beverage. The hypothesis of our study is that an AGE-rich beverage acutely impairs FMD more than a beverage with a low AGE content.

Secondary Outcomes

  • Postprandial Change from Baseline in Microcirculation (Laser-Doppler measurements of reactive hyperemia at the hand)(Baseline, 90 and 180 min. following food AGE intake.)

Study Sites (1)

Loading locations...

Similar Trials